OpenLB
Open Library of Bioscience
Advanced Search
International journal of molecular sciences
Nov 08, 2022;23 (22):

New Drugs and Novel Cellular Targets against Tuberculosis.

Giulia Degiacomi, Vadim Makarov, Maria Rosalia Pasca, Laurent Roberto Chiarelli
Author Information
  1. Giulia Degiacomi: Department of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, 27100 Pavia, Italy. ORCID
  2. Vadim Makarov: Research Center of Biotechnology RAS, 119071 Moscow, Russia. ORCID
  3. Maria Rosalia Pasca: Department of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, 27100 Pavia, Italy. ORCID
  4. Laurent Roberto Chiarelli: Department of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, 27100 Pavia, Italy. ORCID
PMID: 36430162 DOI: 10.3390/ijms232213680

Abstract

() is the etiological agent of tuberculosis (TB), one of the most life-threatening communicable diseases, which causes 10 million new cases each year and results in an estimated 1 [...].

References

  1. Int J Mol Sci. 2020 Dec 13;21(24): [PMID: 33322180]
  2. Int J Mol Sci. 2021 Nov 10;22(22): [PMID: 34830070]
  3. Int J Mol Sci. 2021 Dec 10;22(24): [PMID: 34948114]
  4. Int J Mol Sci. 2022 Feb 10;23(4): [PMID: 35216083]
  5. Int J Mol Sci. 2022 Jan 11;23(2): [PMID: 35054958]
  6. Int J Mol Sci. 2021 Dec 09;22(24): [PMID: 34948055]
  7. Int J Mol Sci. 2021 Nov 09;22(22): [PMID: 34830021]
  8. Int J Mol Sci. 2021 Aug 04;22(16): [PMID: 34445098]

MeSH Term

Humans
Tuberculosis
Mycobacterium tuberculosis
Communicable Diseases
Editorial
Article has an altmetric score of 1

Word Cloud

Created with Highcharts 10.0.0etiologicalagenttuberculosisTBonelife-threateningcommunicablediseasescauses10millionnewcasesyearresultsestimated1[]NewDrugsNovelCellularTargetsTuberculosis

Similar Articles

Cited By